Evidence map›Paper›PMID 26114093›Full record

ArticleTranslational cancer research2015

The promise and challenge of ovarian cancer models.

Noor Hasan, Anders W Ohman, Daniela M Dinulescu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Marine Collagen Substrates for 2D and 3D Ovarian Cancer Cell Systems.Frontiers in bioengineering and biotechnology · 2019
    Article
  18. Review
  19. Ovarian Cancer Prevention in High-risk Women.Clinical obstetrics and gynecology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Noor HasanDepartment of Pathology, Division of Women's and Perinatal Pathology, Eugene Braunwald Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Anders W OhmanDepartment of Pathology, Division of Women's and Perinatal Pathology, Eugene Braunwald Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Daniela M DinulescuDepartment of Pathology, Division of Women's and Perinatal Pathology, Eugene Braunwald Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Brigham and Women's Hospital · US

Funding

Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian CancerR03CA189462 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI DINULESCU, DANIELA M · 2014 to 2015
$170k
NCI NIH HHS R03 CA189462Wellcome Trust
6 · The paper itself

Abstract

The complexity and heterogeneity of ovarian cancer cases are difficult to reproduce in

Indexed as

Animal modelsavatargenetically engineered mouse model (GEMM)laying hen modelovarian cancer

Identifiers

PMID26114093
PMCPMC4477961
OpenAlexW2177410322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.